WAVE (unphosphorylated Tyr-150) Blocking Peptide
€155.00
In stock
SKU
ECM-WX2125
Background:
The Wiskott–Aldrich syndrome protein (WASP) family is involved in various pathways that regulate actin cytoskeletal organization. This family includes WASP, N-WASP, and three WAVE/SCAR isoforms, WAVEs 1, 2, and 3. WAVE proteins play key roles in actin-mediated cell events, such as membrane ruffling and lamellipodia formation. WAVEs contain an N-terminal WAVE homology domain, a basic domain, a Proline-rich region, and carboxy terminal verprolin, cofilin, and acidic (VCA) region. WAVEs are thought to act downstream of the Rac GTPase, connecting Rac activation to induction of Arp 2/3-mediated actin polymerization. Regulation of WAVE activity can occur through tyrosine phosphorylation. Src phosphorylation of WAVE1 at Tyr-125 enhances binding to the Arp2/3 complex, and is required for WAVE inhibition of Arp2/3-mediated stress fiber formation. By contrast, WAVE2 phosphorylation of Tyr-150 by Abl may enhance Arp2/3 complex actin nucleation and microspike formation in fibroblasts. Thus, site-specific tyrosine phosphorylation may be important for controlling specific activities of WAVE proteins.
Sequence: Unphosphorylated WAVE (Tyr-150) synthetic peptide corresponds to amino acid residues surrounding the Tyr-150 in human WAVE2. This sequence has high homology with similar regions in rat and mouse WAVE2, and to similar regions in the conserved site in WAVE1 (Tyr-151) and WAVE3 (Tyr-151).
Specificity: This peptide can be used as an unphosphorylated control peptide for WAVE (Tyr-150) antibody (WP1821). It is the unphosphorylated version of phospho-WAVE (Tyr-150) peptide (WX1825), and it does not block WP1821 reactivity in Western blot, demonstrating the phospho-specificity of WP1821.
Application dilution:
Blocking: 1:1000
ELISA: 50 ng/well
End user should determine optimal dilution for their particular applications and experiments.Western blot membranes were incubated with diluted antibody in 5% non-fat milk, PBS, 0.04% Tween20 for 1 hour at room temperature.
Buffer/Storage:
Blocking Peptide is supplied in 50µl phosphate-buffered saline and 0.05% sodium azide. Store at –20°C. Stable for 1 year.
The Wiskott–Aldrich syndrome protein (WASP) family is involved in various pathways that regulate actin cytoskeletal organization. This family includes WASP, N-WASP, and three WAVE/SCAR isoforms, WAVEs 1, 2, and 3. WAVE proteins play key roles in actin-mediated cell events, such as membrane ruffling and lamellipodia formation. WAVEs contain an N-terminal WAVE homology domain, a basic domain, a Proline-rich region, and carboxy terminal verprolin, cofilin, and acidic (VCA) region. WAVEs are thought to act downstream of the Rac GTPase, connecting Rac activation to induction of Arp 2/3-mediated actin polymerization. Regulation of WAVE activity can occur through tyrosine phosphorylation. Src phosphorylation of WAVE1 at Tyr-125 enhances binding to the Arp2/3 complex, and is required for WAVE inhibition of Arp2/3-mediated stress fiber formation. By contrast, WAVE2 phosphorylation of Tyr-150 by Abl may enhance Arp2/3 complex actin nucleation and microspike formation in fibroblasts. Thus, site-specific tyrosine phosphorylation may be important for controlling specific activities of WAVE proteins.
Sequence: Unphosphorylated WAVE (Tyr-150) synthetic peptide corresponds to amino acid residues surrounding the Tyr-150 in human WAVE2. This sequence has high homology with similar regions in rat and mouse WAVE2, and to similar regions in the conserved site in WAVE1 (Tyr-151) and WAVE3 (Tyr-151).
Specificity: This peptide can be used as an unphosphorylated control peptide for WAVE (Tyr-150) antibody (WP1821). It is the unphosphorylated version of phospho-WAVE (Tyr-150) peptide (WX1825), and it does not block WP1821 reactivity in Western blot, demonstrating the phospho-specificity of WP1821.
Application dilution:
Blocking: 1:1000
ELISA: 50 ng/well
End user should determine optimal dilution for their particular applications and experiments.Western blot membranes were incubated with diluted antibody in 5% non-fat milk, PBS, 0.04% Tween20 for 1 hour at room temperature.
Buffer/Storage:
Blocking Peptide is supplied in 50µl phosphate-buffered saline and 0.05% sodium azide. Store at –20°C. Stable for 1 year.
| Is Featured? | No |
|---|
Write Your Own Review